Director STOELTING sold 9,000 shares in 2 transactions at $180.00–$200.00, reducing stake by 44.7%, as RRX stock trades at 52-week high
Director Curtis W Stoelting executed 2 separate sales totaling 9,000 shares for $1,710,000.00 on February 4–5, 2026, at a blended average price of $190.00. Post-transaction holdings fell to 11,116 shares from 20,116 shares, representing a 44.7% reduction in his position. The sales occurred as RRX trades at its 52-week high of $211.80 (the current price is 0.0% from the high reached during the filing window), and the stock has appreciated 40.8% over 30 days and 55.8% over 90 days. The P/E of 54.73 is elevated relative to fundamentals (net income of $79,600,000.00 on revenue of $1,497,000,000.00, with annual revenue growth of -3.5%), suggesting the stock is trading at a premium multiple at the time of sale. The substantial reduction in directorate stake warrants monitoring of whether additional insider activity or company developments emerge.